SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial

Nobuya Inagaki, Hitoshi Onouchi, Hiroki Sano, Nobuo Funao, Shingo Kuroda, Kohei Kaku

The Lancet Diabetes & Endocrinology · 2013 · 55 citations · 9 references

Concepts

References

9